acetylglucosamine has been researched along with Kahler Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dagbashyan, SS; Gasparyan, VK; Melkikyan, NA; Melkonyan, VZ | 1 |
Ilić, V; Marković, D; Milosević-Jovcić, N; Petrović, S; Ristić, T; Stefanović, G | 1 |
Ihara, Y; Kanayama, Y; Matuzawa, Y; Nakao, H; Nishikawa, A; Nishiura, T; Taniguchi, N; Yoshimura, M | 1 |
3 other study(ies) available for acetylglucosamine and Kahler Disease
Article | Year |
---|---|
Diagnosis of multiple myeloma using enzyme immunoassay for detection of antibodies to N-acetyl glucosamine on microparticles.
Topics: Acetylglucosamine; Antibodies; Humans; Immunoenzyme Techniques; Multiple Myeloma; Particle Size | 2008 |
Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR.
Topics: Acetylglucosamine; Galactose; Glycosylation; Humans; Immunoglobulin G; Lectins; Multiple Myeloma; N-Acetylneuraminic Acid; Paraproteins; Phosphorylation; Phosphotyrosine; Receptors, Antigen, B-Cell; Signal Transduction | 2008 |
High expression of UDP-N-acetylglucosamine: beta-D mannoside beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in chronic myelogenous leukemia in blast crisis.
Topics: Acetylglucosamine; Blast Crisis; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glycosylation; Humans; Immunoblotting; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Leukocyte Common Antigens; Mannose; Molecular Probe Techniques; Multiple Myeloma; N-Acetylglucosaminyltransferases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Processing, Post-Translational; RNA, Messenger; Tumor Cells, Cultured | 1995 |